TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics

Journal of Immunology

Volumn 194, Issue 7, 2015, Pages 3035-3044

  Simchoni, Noa ^a   Cunningham Rundles, Charlotte ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AUTOANTIBODY; CD40 LIGAND; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M; INTERLEUKIN 21; MEMBRANE PROTEIN; PROTEIN CDR3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; COMPLEMENTARITY DETERMINING REGION; INTERLEUKIN DERIVATIVE; LYMPHOCYTE ANTIGEN RECEPTOR;

AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; CELL INTERACTION; CELL LINEAGE; CONTROLLED STUDY; GENE CLUSTER; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; HEP 2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; IMMUNOGLOBULIN STRUCTURE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; AGONISTS; AUTOIMMUNITY; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL NUCLEUS; CLUSTER ANALYSIS; COMPLEMENTARITY DETERMINING REGION; DRUG EFFECTS; GENETICS; HIGH THROUGHPUT SEQUENCING; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PLASMA CELL;

ANTIBODY FORMATION; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; CD40 LIGAND; CELL DIFFERENTIATION; CELL NUCLEUS; CLUSTER ANALYSIS; COMPLEMENTARITY DETERMINING REGIONS; GENETIC LOCI; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; INTERLEUKINS; LYMPHOCYTE ACTIVATION; PHENOTYPE; PLASMA CELLS; RECEPTORS, ANTIGEN, B-CELL; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 84925851902     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402690     Document Type: Article

References (69)

1. Bekeredjian-Ding, I. B., M. Wagner, V. Hornung, T. Giese, M. Schnurr, S. Endres, and G. Hartmann. 2005. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J. Immunol. 174: 4043-4050.
2. Glaum, M. C., S. Narula, D. Song, Y. Zheng, A. L. Anderson, C. H. Pletcher, and A. I. Levinson. 2009. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production. J. Allergy Clin. Immunol. 123: 224-230.e4.
3. He, B., X. Qiao, and A. Cerutti. 2004. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J. Immunol. 173: 4479-4491.
4. Bernasconi, N. L., N. Onai, and A. Lanzavecchia. 2003. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101: 4500-4504.
5. Giordani, L., M. Sanchez, I. Libri, M. G. Quaranta, B. Mattioli, and M. Viora. 2009. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production. J. Leukoc. Biol. 86: 261-271.
6. Capolunghi, F., S. Cascioli, E. Giorda, M. M. Rosado, A. Plebani, C. Auriti, G. Seganti, R. Zuntini, S. Ferrari, M. Cagliuso, et al. 2008. CpG drives human transitional B cells to terminal differentiation and production of natural antibodies. J. Immunol. 180: 800-808.
7. Maglione, P. J., N. Simchoni, S. Black, L. Radigan, J. R. Overbey, E. Bagiella, J. B. Bussel, X. Bossuyt, J. L. Casanova, I. Meyts, et al. 2014. IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigens. Blood 124: 3561-3571.
8. So, N. S., M. A. Ostrowski, and S. D. Gray-Owen. 2012. Vigorous response of human innate functioning IgM memory B cells upon infection by Neisseria gonorrhoeae. J. Immunol. 188: 4008-4022.
9. Gunn, K. E., and J. W. Brewer. 2006. Evidence that marginal zone B cells possess an enhanced secretory apparatus and exhibit superior secretory activity. J. Immunol. 177: 3791-3798.
10. Martin, F., A. M. Oliver, and J. F. Kearney. 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629.
11. Genestier, L., M. Taillardet, P. Mondiere, H. Gheit, C. Bella, and T. Defrance. 2007. TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses. J. Immunol. 178: 7779-7786.
12. Fagarasan, S., N. Watanabe, and T. Honjo. 2000. Generation, expansion, migration and activation of mouse B1 cells. Immunol. Rev. 176: 205-215.
13. Gray, D., I. C. MacLennan, H. Bazin, and M. Khan. 1982. Migrant mu+ delta+ and static mu+ delta- B lymphocyte subsets. Eur. J. Immunol. 12: 564-569.
14. Oliver, A. M., F. Martin, and J. F. Kearney. 1999. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162: 7198-7207.
15. Avery, D. T., J. I. Ellyard, F. Mackay, L. M. Corcoran, P. D. Hodgkin, and S. G. Tangye. 2005. Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage. J. Immunol. 174: 4034-4042.
16. Zotos, D., J. M. Coquet, Y. Zhang, A. Light, K. D'Costa, A. Kallies, L. M. Corcoran, D. I. Godfrey, K. M. Toellner, M. J. Smyth, et al. 2010. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 207: 365-378.
17. Alamyar, E., P. Duroux, M. P. Lefranc, and V. Giudicelli. 2012. IMGT(®) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS. Methods Mol. Biol. 882: 569-604.
18. Munshaw, S., and T. B. Kepler. 2010. SoDA2: a Hidden Markov Model approach for identification of immunoglobulin rearrangements. Bioinformatics 26: 867-872.
19. R Development Core Team. 2014. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. Available at: http://www.R-project.org.
20. RStudio, Inc. 2012. RStudio: Integrated development environment for R. RStudio, Inc., Boston, MA. http://www.rstudio.com/about/eula/.
21. Wickham, H. 2011. The Split-Apply-Combine Strategy for Data Analysis. J. Stat. Softw. 40: 1-29. Available at: http://www.jstatsoft.org/v40/i01.
22. Wickham, H. 2009. ggplot2: Elegant Graphics for Data Analysis. Springer, New York.
23. Wickham, H. 2007. Reshaping data with the reshape package. J. Stat. Softw. 21: 1-29. Available at: http://www.jstatsoft.org/v21/i12.
24. Maechler, M., P. Rousseeuw, A. Struyf, M. Hubert, and K. Hornik. 2015. cluster: Cluster Analysis Extended. R package version 2.0.1. Available at: http://cran.r-project.org/web/packages/cluster/index.html.
25. Carlson, C. S., R. O. Emerson, A. M. Sherwood, C. Desmarais, M. W. Chung, J. M. Parsons, M. S. Steen, M. A. LaMadrid-Herrmannsfeldt, D. W. Williamson, R. J. Livingston, et al. 2013. Using synthetic templates to design an unbiased multiplex PCR assay. Nat. Commun. 4: 2680.
26. Throsby, M., E. van den Brink, M. Jongeneelen, L. L. Poon, P. Alard, L. Cornelissen, A. Bakker, F. Cox, E. van Deventer, Y. Guan, et al. 2008. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE 3: e3942.
27. Johnson, T. A., L. Z. Rassenti, and T. J. Kipps. 1997. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J. Immunol. 158: 235-246.
28. Seifert, M., S. A. Steimle-Grauer, T. Goossens, M. L. Hansmann, A. Bräuninger, and R. Küppers. 2009. A model for the development of human IgD-only B cells: Genotypic analyses suggest their generation in superantigen driven immune responses. Mol. Immunol. 46: 630-639.
29. Dal-Bo, M., I. Del Giudice, R. Bomben, D. Capello, F. Bertoni, F. Forconi, L. Laurenti, D. Rossi, A. Zucchetto, G. Pozzato, et al. 2011. B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage. Br. J. Haematol. 153: 3-14.
30. Thorpe, S. J., C. E. Turner, F. K. Stevenson, M. B. Spellerberg, R. Thorpe, J. B. Natvig, and K. M. Thompson. 1998. Human monoclonal antibodies encoded by the V4-34 gene segment show cold agglutinin activity and variable multireactivity which correlates with the predicted charge of the heavy-chain variable region. Immunology 93: 129-136.
31. Di Niro, R., L. Mesin, M. Raki, N. Y. Zheng, F. Lund-Johansen, K. E. Lundin, A. Charpilienne, D. Poncet, P. C. Wilson, and L. M. Sollid. 2010. Rapid generation of rotavirus-specific human monoclonal antibodies from small-intestinal mucosa. J. Immunol. 185: 5377-5383.
32. Di Niro, R., L. Mesin, N. Y. Zheng, J. Stamnaes, M. Morrissey, J. H. Lee, M. Huang, R. Iversen, M. F. du Pré, S. W. Qiao, et al. 2012. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat. Med. 18: 441-445.
33. Xu, J. L., and M. M. Davis. 2000. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13: 37-45.
34. Wardemann, H., S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, and M. C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377.
35. Klein, U., K. Rajewsky, and R. Küppers. 1998. Human immunoglobulin (Ig)M+ IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188: 1679-1689.
36. Poeck, H., M. Wagner, J. Battiany, S. Rothenfusser, D. Wellisch, V. Hornung, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann. 2004. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood 103: 3058-3064.
37. Weller, S., M. C. Braun, B. K. Tan, A. Rosenwald, C. Cordier, M. E. Conley, A. Plebani, D. S. Kumararatne, D. Bonnet, O. Tournilhac, et al. 2004. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 104: 3647-3654.
38. Berkowska, M. A., G. J. Driessen, V. Bikos, C. Grosserichter-Wagener, K. Stamatopoulos, A. Cerutti, B. He, K. Biermann, J. F. Lange, M. van der Burg, et al. 2011. Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood 118: 2150-2158.
39. Wu, Y. C., D. Kipling, H. S. Leong, V. Martin, A. A. Ademokun, and D. K. Dunn-Walters. 2010. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. Blood 116: 1070-1078.
40. Weller, S., M. Bonnet, H. Delagreverie, L. Israel, M. Chrabieh, L. Maródi, C. Rodriguez-Gallego, B. Z. Garty, C. Roifman, A. C. Issekutz, et al. 2012. IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients. Blood 120: 4992-5001.
41. Aranburu, A., S. Ceccarelli, E. Giorda, R. Lasorella, G. Ballatore, and R. Carsetti. 2010. TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells. J. Immunol. 185: 7293-7301.
42. Ehlers, M., H. Fukuyama, T. L. McGaha, A. Aderem, and J. V. Ravetch. 2006. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med. 203: 553-561.
43. Celhar, T., R. Magalhães, and A. M. Fairhurst. 2012. TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunol. Res. 53: 58-77.
44. Christensen, S. R., J. Shupe, K. Nickerson, M. Kashgarian, R. A. Flavell, and M. J. Shlomchik. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417-428.
45. Nickerson, K. M., S. R. Christensen, J. Shupe, M. Kashgarian, D. Kim, K. Elkon, and M. J. Shlomchik. 2010. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J. Immunol. 184: 1840-1848.
46. Chauhan, S. K., V. V. Singh, R. Rai, M. Rai, and G. Rai. 2013. Distinct auto-antibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. J. Clin. Immunol. 33: 954-964.
47. Laska, M. J., A. Troldborg, B. Hansen, K. Stengaard-Pedersen, P. Junker, B. A. Nexø, and A. Voss. 2014. Polymorphisms within Toll-like receptors are associated with systemic lupus erythematosus in a cohort of Danish females. Rheumatology (Oxford) 53: 48-55.k
48. Mu, R., X. Y. Sun, L. T. Lim, C. H. Xu, C. X. Dai, Y. Su, R. L. Jia, and Z. G. Li. 2012. Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population. Chin. Med. J. (Engl.) 125: 2873-2877.
49. Wandstrat, A. E., F. Carr-Johnson, V. Branch, H. Gray, A. M. Fairhurst, A. Reimold, D. Karp, E. K. Wakeland, and N. J. Olsen. 2006. Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus. J. Autoimmun. 27: 153-160.
50. Tiller, T., M. Tsuiji, S. Yurasov, K. Velinzon, M. C. Nussenzweig, and H. Wardemann. 2007. Autoreactivity in human IgG+ memory B cells. Immunity 26: 205-213.
51. Grönwall, C., J. Vas, and G. J. Silverman. 2012. Protective roles of natural IgM antibodies. Front. Immunol. 3: 66.
52. Mannoor, K., A. Matejuk, Y. Xu, M. Beardall, and C. Chen. 2012. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival. J. Immunol. 188: 3628-3638.
53. Chikazawa, M., N. Otaki, T. Shibata, H. Miyashita, Y. Kawai, S. Maruyama, S. Toyokuni, Y. Kitaura, T. Matsuda, and K. Uchida. 2013. Multispecificity of immunoglobulin M antibodies raised against advanced glycation end products: involvement of electronegative potential of antigens. J. Biol. Chem. 288: 13204-13214.
54. Mannoor, K., Y. Xu, and C. Chen. 2013. Natural autoantibodies and associated B cells in immunity and autoimmunity. Autoimmunity 46: 138-147.
55. Gururajan, M., J. Jacob, and B. Pulendran. 2007. Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets. PLoS ONE 2: e863.
56. Tornberg, U. C., and D. Holmberg. 1995. B-1a, B-1b and B-2 B cells display unique VHDJH repertoires formed at different stages of ontogeny and under different selection pressures. EMBO J. 14: 1680-1689.
57. Reap, E. A., E. S. Sobel, P. L. Cohen, and R. A. Eisenberg. 1993. Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice. J. Exp. Med. 177: 69-78.
58. Descatoire, M., J. C. Weill, C. A. Reynaud, and S. Weller. 2011. A human equivalent of mouse B-1 cells? J. Exp. Med. 208: 2563-2564, author reply 2566-2569.
59. Perez-Andres, M., C. Grosserichter-Wagener, C. Teodosio, J. J. van Dongen, A. Orfao, and M. C. van Zelm. 2011. The nature of circulating CD27+CD43+ B cells. J. Exp. Med. 208: 2565-2566, author reply 2566-2569.
60. Griffin, D. O., N. E. Holodick, and T. L. Rothstein. 2011. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-. J. Exp. Med. 208: 67-80.
61. - B1 cell subsets reveals potential cell sorting artifacts. J. Exp. Med. 209: 433-434, author reply 434-436.
62. Tangye, S. G. 2013. To B1 or not to B1: that really is still the question! Blood 121: 5109-5110.
63. Covens, K., B. Verbinnen, N. Geukens, I. Meyts, F. Schuit, L. Van Lommel, M. Jacquemin, and X. Bossuyt. 2013. Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype. Blood 121: 5176-5183.
64. Cerutti, A., M. Cols, and I. Puga. 2013. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat. Rev. Immunol. 13: 118-132.
65. Vollmer, J., and A. M. Krieg. 2009. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv. Drug Deliv. Rev. 61: 195-204.
66. Bode, C., G. Zhao, F. Steinhagen, T. Kinjo, and D. M. Klinman. 2011. CpG DNA as a vaccine adjuvant. Expert Rev. Vaccines 10: 499-511.
67. Gungor, B., F. C. Yagci, G. Tincer, B. Bayyurt, E. Alpdundar, S. Yildiz, M. Ozcan, I. Gursel, and M. Gursel. 2014. CpG ODN nanorings induce IFNα from plasmacytoid dendritic cells and demonstrate potent vaccine adjuvant activity. Sci. Transl. Med. 6: 35ra61.
68. Cooper, C. L., H. L. Davis, M. L. Morris, S. M. Efler, M. A. Adhami, A. M. Krieg, D. W. Cameron, and J. Heathcote. 2004. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. J. Clin. Immunol. 24: 693-701.
69. Cooper, C. L., H. L. Davis, J. B. Angel, M. L. Morris, S. M. Elfer, I. Seguin, A. M. Krieg, and D. W. Cameron. 2005. CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults. AIDS 19: 1473-1479.